Clinical Trial Update: The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy

View source ↗

Summary

A clinical trial update on how the intestinal microbiome may influence response to immunotherapy in triple-negative breast cancer; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Breast Neoplasms | Status: RECRUITING